{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:24:45Z","timestamp":1790515485553,"version":"4.1.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Previous research in patients with schizophrenia in European and USA population groups has demonstrated a high prevalence of metabolic syndrome and disease progression (~35%\u201340%) and increased risk for cardiovascular disease and long-term mortality. Limited research has determined the prevalence of existing cardiometabolic risk factors at onset of a first episode psychosis. This cross-sectional study presents a clinical overview of the cardiometabolic risk profile in young people with first episode psychosis in the UK. Forty-six participants (72% male) clinically diagnosed with first episode psychosis (n = 25), schizophrenia (n = 13), bipolar disorder (n = 4), unspecified non-organic psychosis (n = 2) or acute psychotic episode (n = 2) with &amp;lt; 6 months Duration of Untreated Psychosis (DUP; mean 33.4 \u00b1 37.2 days) were assessed for anthropometric, health risk behaviors and clinical measurements including resting heart rate, blood pressure, blood lipids, glycated hemoglobin, and prolactin. Overall, participants (aged 18\u201337 years) had a high prevalence of cardiometabolic risk factors due to: elevated values for BMI (73%) and abdominal adiposity (50%), blood pressure (47% prehypertensive; 23% hypertensive), resting heart rate (43%); hypercholesterolemia (32%); suboptimal HDL-C levels (36%); and hypertriglyceridemia (40%). Participants also self-reported poor health risk habits including smoking (55%), alcohol use (39%), substance use (18%), poor diet (52%), and sedentary behavior (29%). Young people with psychosis are at increased risk for cardiometabolic disorders due to elevated clinical markers and health risk behaviors. Physical health interventions (including health behavior advice) are needed early in the treatment process to address this increased risk for cardiometabolic disorders in individuals recently diagnosed with psychosis.<\/jats:p>","DOI":"10.3389\/fendo.2020.564240","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T06:28:46Z","timestamp":1606199326000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Cardiometabolic Risk in First Episode Psychosis Patients"],"prefix":"10.3389","volume":"11","author":[{"given":"Jo","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Band","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Horne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.1314","article-title":"Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study","volume":"71","author":"Correll","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.2","article-title":"Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis","volume":"68","author":"Foley","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/schbul\/sbs082","article-title":"Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr Bull"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20069","article-title":"A meta-analysis of cardio-metabolic abnormalities in drug na\u00efve, first-episode and multi-episode patients with schizophrenia versus general population controls","volume":"12","author":"Vancampfort","year":"2013","journal-title":"World Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.109.067512","article-title":"Twenty-five year mortality of a community cohort with schizophrenia","volume":"196","author":"Brown","year":"2010","journal-title":"Br J Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2013.07.011","article-title":"Schizophrenia and the risk of cardiovascular diseases: a meta-analysis of thirteen cohort studies","volume":"47","author":"Fan","year":"2013","journal-title":"J Psychiatr Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.110.085100","article-title":"Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders","volume":"199","author":"Wahlbeck","year":"2011","journal-title":"Br J Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796017000166","article-title":"Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study","volume":"27","author":"Westman","year":"2018","journal-title":"Epidemiol Psychiatr Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/0004867412453089","article-title":"Cardiometabolic risk factors in people with psychotic disorders: the second Australian national survey of psychosis","volume":"46","author":"Galletly","year":"2012","journal-title":"Aust N Z J Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291715000562","article-title":"Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial","volume":"45","author":"Gardner-Sood","year":"2015","journal-title":"Psychol Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2009.01038.x","article-title":"Obesity, serious mental illness and antipsychotic drugs","volume":"11","author":"Holt","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5414\/NEPBand23071","article-title":"Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy","volume":"23","author":"Riecher-R\u00f6ssler","year":"2009","journal-title":"Neuropsychiatry"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11r07222","article-title":"Tobacco use before, at, and after first-episode psychosis: a systematic meta-analysis","volume":"73","author":"Myles","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2009.01.005","article-title":"Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)","volume":"24","author":"De Hert","year":"2009","journal-title":"Eur Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.042853","article-title":"Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials","volume":"193","author":"\u00c1lvarez-Jim\u00e9nez","year":"2008","journal-title":"Br J Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7893.2011.00262.x","article-title":"Metabolic abnormalities in an early psychosis service: a retrospective, naturalistic cross-sectional study","volume":"5","author":"Curtis","year":"2011","journal-title":"Early Interv Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1600-0447.2008.01317.x","article-title":"The metabolic syndrome and schizophrenia","volume":"119","author":"Meyer","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"B19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.psyneuen.2015.09.005","article-title":"Glucose disturbances in first-episode drug-na\u00efve schizophrenia: relationship to psychopathology","volume":"62","author":"Zhang","year":"2015","journal-title":"Psychoneuroendocrino"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.117.200907","article-title":"Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis","volume":"211","author":"Pillinger","year":"2017","journal-title":"Br J Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30262-0","article-title":"The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis","volume":"3","author":"Perry","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2008.01334.x","article-title":"Which comes first: atypical antipsychotic treatment or cardiometabolic risk","volume":"119","author":"Stahl","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1092852918001311","article-title":"High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine","volume":"24","author":"Larsen","year":"2018","journal-title":"CNS Spectr"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000465","article-title":"Risk of new-onset diabetes after long-term treatment with clozapine in comparison to other antipsychotics in patients with schizophrenia","volume":"36","author":"Schulte","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n1007","article-title":"Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients","volume":"65","author":"Arranz","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2015.07.041","article-title":"Parameters of glucose and lipid metabolism at the fasted state in drug-naive first-episode patients with psychosis: evidence for insulin resistance","volume":"229","author":"Petrikis","year":"2015","journal-title":"Psychiatry Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia","volume":"160","author":"Ryan","year":"2003","journal-title":"Am J Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2019.159","article-title":"Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study","volume":"215","author":"Gaughran","year":"2019","journal-title":"Br J Psychiatry (2019)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2016.3803","article-title":"Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis","volume":"74","author":"Pillinger","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2015.07.053","article-title":"Videbech P. Metabolic syndrome and aerobic fitness in patients with first-episode schizophrenia, including a 1-year follow-up","volume":"168","author":"Nyboe","year":"2015","journal-title":"Schizophr Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbw127","article-title":"Diagnostic categories: provisional, not otherwise classified, or place-holder","volume":"42","author":"Carpenter","year":"2016","journal-title":"Schizophr Bull"},{"key":"B34","volume-title":"International statistical classification of diseases and related health problems: 10th revision (ICD-10)","year":"2010"},{"key":"B35","volume-title":"Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8-11 December 2008","year":"2011"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome\u2014a new world-wide definition. A consensus statement from the international diabetes federation","volume":"23","author":"Albert","year":"2006","journal-title":"Diabet Med"},{"key":"B37","volume-title":"Positive cardiometabolic health resource: an intervention framework for patients with psychosis and schizophrenia. 2014 update","author":"Shiers","year":"2014"},{"key":"B38","volume-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor","year":"2005"},{"key":"B39","unstructured":"Health Survey for England. Fruit and Vegetable Consumption"},{"key":"B40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/1049731503257667","article-title":"Validating the alcohol use disorders identification test with persons who have a serious mental illness","volume":"14","author":"O\u2019Hare","year":"2004","journal-title":"Res Soc Work Pract"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0b013e3182630ec1","article-title":"Initial validation of an exercise \u201cvital sign\u201d in electronic medical records","volume":"44","author":"Coleman","year":"2012","journal-title":"Med Sci Sports Exerc"},{"key":"B42","volume-title":"ACSM\u2019s Guidelines for Exercise Testing and Prescription","author":"Riebe","year":"2018"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/eip.12406","article-title":"Counting up the risks: how common are risk factors for morbidity and mortality in young people with psychosis","volume":"12","author":"Hahn","year":"2018","journal-title":"Early Interv Psychiatry"},{"key":"B44","unstructured":"NHS DigitalHealth Survey for England 2015: Adult and Overweight and Obesity"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20252","article-title":"Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis","volume":"14","author":"Vancampfort","year":"2015","journal-title":"World Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2012.03.046","article-title":"Associations between sedentary behaviour and metabolic parameters in patients with schizophrenia","volume":"200","author":"Vancampfort","year":"2012","journal-title":"Psychiatry Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1176\/appi.ps.201200143","article-title":"Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999\u20132011","volume":"64","author":"Dickerson","year":"2013","journal-title":"Psychiatr Serv"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12160","article-title":"Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population","volume":"16","author":"Bly","year":"2014","journal-title":"Bipolar Disord"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.6119","article-title":"Obesity and excessive weight gain in young adults: new targets\u00a0for prevention","volume":"318","author":"Dietz","year":"2017","journal-title":"JAMA"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20309","article-title":"Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large-scale meta-analysis","volume":"15","author":"Vancampfort","year":"2016","journal-title":"World Psychiatry"},{"key":"B51","unstructured":"Adult smoking habits in the UK2016"},{"key":"B52","unstructured":"Adult drinking habits in Great Britain: 2005 to 2016"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2019.05.002","article-title":"Tobacco smoking and nicotine dependence in first episode and established psychosis","volume":"43","author":"Lally","year":"2019","journal-title":"Asian J Psychiatr"},{"key":"B54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-4613-1837-8_7","article-title":"The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence","volume-title":"The cocaine crisis","author":"Khantzian","year":"1987"},{"key":"B55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5498\/wjp.v5.i1.35","article-title":"Smoking in schizophrenic patients: a critique of the self-medication hypothesis","volume":"5","author":"Manzella","year":"2015","journal-title":"World J Psychiatry"},{"key":"B56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0277-9536(01)00008-9","article-title":"Smoking and quitting: a qualitative study with community living psychiatric clients","volume":"54","author":"Lawn","year":"2002","journal-title":"Soc Sci Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.51.12.1544","article-title":"A focus group pilot study of tobacco smoking among psychosocial rehabilitation clients","volume":"51","author":"Luckstead","year":"2000","journal-title":"Psychiatr Serv"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1407211","article-title":"Smoking and mortality\u2014beyond established causes","volume":"372","author":"Carter","year":"2015","journal-title":"N Engl J Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S2215-0366(15)00091-7","article-title":"Bespoke smoking cessation for people with severe mental ill health (SCIMITAR): a pilot randomised controlled trial","volume":"2","author":"Gilbody","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30047-1","article-title":"Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial","volume":"6","author":"Gilbody","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2007.112060","article-title":"Smoking cessation rates in the United States: a comparison of young adult and older smokers","volume":"98","author":"Messer","year":"2008","journal-title":"Am J Public Health"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00683","article-title":"y-QUIT: smoking prevalence, engagement, and effectiveness of an individualized smoking cessation intervention in youth with severe mental illness","volume":"9","author":"Curtis","year":"2018","journal-title":"Front Psychiatry"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.04.009","article-title":"The inadmissibility of What We Eat In America and NHANES dietary data in nutrition and obesity research and the scientific formulation of national dietary guidelines","volume":"90","author":"Archer","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3945\/an.114.006189","article-title":"Considering the value of dietary assessment data in informing nutrition-related health policy","volume":"5","author":"H\u00e9bert","year":"2014","journal-title":"Adv Nutr"},{"key":"B65","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3945\/an.114.007492","article-title":"Understanding nutritional epidemiology and its role in policy","volume":"6","author":"Satija","year":"2015","journal-title":"Adv Nutr"},{"key":"B66","volume-title":"Psychosis and Schizophrenia in Adults: Treatment and Management. NICE Clinical Guideline 178","year":"2014"},{"key":"B67","volume-title":"Psychosis and schizophrenia in adults - Quality Standard (QS80)","year":"2015"},{"key":"B68","unstructured":"Commissioning for Quality and Innovation (CQUIN). Guidance for 2017-2019"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.564240\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T06:29:20Z","timestamp":1606199360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.564240\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":68,"alternative-id":["10.3389\/fendo.2020.564240"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.564240","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"article-number":"564240"}}